In the United States, Oregon and Virginia have placed Flualprazolam into Schedule I.[16] On December 23, 2022, the DEA announced it had begun consideration on the matter of placing Flualprazolam under temporary Schedule I status.[17] Later on July 25, 2023, the DEA published a pre-print notice that Flualprazolam would become temporarily scheduled as a Schedule I controlled substance from 26 July 2023 to 26 July 2025.[18]
^Rice K, Hikin L, Lawson A, Smith PR, Morley S (April 2021). "Quantification of Flualprazolam in Blood by LC-MS-MS: A Case Series of Nine Deaths". Journal of Analytical Toxicology. 45 (4): 410–416. doi:10.1093/jat/bkaa098. PMID32780842.
^Ling J, Zhang W, Yan X, Liu W, Wang Y, Ding Y (August 2022). "Sensitive detection and primary metabolism analysis of flualprazolam in blood". Journal of Forensic and Legal Medicine. 90: 102388. doi:10.1016/j.jflm.2022.102388. PMID35691207.
^"21 nya droger förbjudna hittills I år" [21 new drugs banned so far this year] (PDF). Svenska Narkotika Polisföreningens Tidskrift [The Journal of the Swedish Narcotics Police Association]. June 2018. Archived from the original(PDF) on 5 August 2018. Retrieved 23 April 2023.
^Moosmann B, Auwärter V (October 2018). "Designer Benzodiazepines: Another Class of New Psychoactive Substances". New Psychoactive Substances. Handbook of Experimental Pharmacology. Vol. 252. Springer International Publishing. pp. 383–410. doi:10.1007/164_2018_154. ISBN978-3-030-10561-7. PMID30367253.
^Chetraru E, Ameline A, Gheddar L, Raul JS, Kintz P (February 2018). "Les "designer benzodiazepines" : qu'en sait-on aujourd'hui ?". Toxicologie Analytique et Clinique. 30 (1): 5–18. doi:10.1016/j.toxac.2017.12.001. ISSN2352-0078.
^Mei V, Concheiro M, Pardi J, Cooper G (October 2019). "Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood". Journal of Analytical Toxicology. 43 (9): 688–695. doi:10.1093/jat/bkz063. PMID31436813.